Rising Incidence Of Chronic Diseases Propels Growth In The Global Multiplex Assay Market Driver: A Major Catalyst in the Evolution of the Multiplex Assays Market in 2025

What combination of drivers is leading to accelerated growth in the multiplex assays market?
The global multiplex assay market is experiencing growth due to a rise in chronic diseases. Multiplex assay, a method heavily used in clinical trials, serves to evaluate the efficacy of a disease and enables the detection of disease-specific antibodies. As reported by the World Health Organization based in Switzerland in September 2023, chronic diseases, also referred to as non-communicable diseases (NCDs), account for 74% of global fatalities, causing 41 million deaths. The escalating occurrence of chronic diseases, therefore, acts as a significant catalyst for the expansion of the global multiplex assay market.

Get Your Multiplex Assays Market Report Here:
https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

What is the projected compound annual growth rate (CAGR) of the multiplex assays market from 2025 to 2034, and what factors influence it?
The market size of multiplex assays has seen significant growth in the past few years. It is projected to increase from $3.67 billion in 2024 to $3.92 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. Factors such as increased spending on healthcare, expansion in emerging markets, rapid advancements in technology, and the swift increase in the aged population have contributed to its growth during the historical period.

Anticipated to witness robust expansion in the forthcoming years, the multiplex assays market is projected to reach a value of $5.42 billion by 2029, with a compound annual growth rate (CAGR) of 8.4%. The market's growth during this forecast period can be credited to factors such as an increase in available funding, efforts initiated by the government towards genetic and microbiological research, an aging demographic, a rise in chronic disease prevalence, and a swift escalation in different bacterial and viral epidemics. Key market trends that are expected to shape this period include a rise in funding for research, governmental initiatives aimed at genetic and microbiological studies, an increasing population of elderly individuals, an uptick in the incidence of chronic ailments, and a fast-paced increase in various bacterial and viral outbreaks.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

What are the most significant trends transforming the multiplex assays market today?
Market players are introducing technologically advanced tests using multiplex assays to improve their market standing. For instance, QuantuMDx Group Limited, a company based in the UK that develops revolutionary point-of-care diagnostics, announced the introduction of its latest respiratory panel test, known as the Q-POC SARS-CoV-2, Flu A/B, and RSV Assay, in May 2022. The innovative Q-POC SARS-CoV-2, Flu A/B, and RSV Assay is designed as a multiplex panel capable of identifying SARS-CoV-2, Flu A, Flu B, and RSV at the need point.

What are the major segments of the multiplex assays market and their role in driving growth?
The multiplex assays market covered in this report is segmented -

1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types
2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies
3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies
4) By Application: Research And Development, Clinical Diagnostics
5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

Subsegments:
1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay), Luminex xMAP Technology, Western Blotting, Immunohistochemistry, Mass Spectrometry-Based Assays
2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction), qPCR (Quantitative PCR), NGS (Next-Generation Sequencing), Microarray Analysis, RT-PCR (Reverse Transcription PCR)
3) By Other Types: Cell-Based Multiplex Assays, Bioanalytical Assays, Imaging-Based Assays, Surface Plasmon Resonance (SPR) Assays

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5775

Which regions are key players in the growth of the multiplex assays market?
North America was the largest region in the multiplex assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the multiplex assays market?
Major companies operating in the multiplex assays market include Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

What Is Covered In The Multiplex Assays Global Market Report?

• Market Size Forecast: Examine the multiplex assays market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the multiplex assays market for a structured understanding.
• Key Players Overview: Analyze major players in the multiplex assays market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the multiplex assays market.
• Segment Contributions: Evaluate how different segments drive overall growth in the multiplex assays market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the multiplex assays market.
• Industry Challenges: Identify potential risks and obstacles affecting the multiplex assays market.
• Competitive Landscape: Review strategic developments in the multiplex assays market, including expansions, agreements, and new product launches.

Market

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.